Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Witte

Showing results (211-220 of 317) with videos related to

Pageof 32
Sort By:
Annals of the Rheumatic Diseases|March 11, 2010
Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren's syndromeBeth L Cobb, Yiping Fei, Roland Jonsson, et al.
RMD Open|April 25, 2024
Primary Sjögren's syndrome independently promotes premature subclinical atherosclerosisNadine Zehrfeld, Malin Abelmann, Sabrina Benz, et al.
Joint Bone Spine|April 20, 2023
What is the best referral strategy for axial spondyloarthritis? A prospective multicenter study in patients with suspicious chronic low back painNelly Ziade, Avin Maroof, Bassel Elzorkany, et al.
Neurological Research and Practice|August 23, 2025
Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumabFranz Felix Konen, Gudrun Mechthild Körner, Martin W Hümmert, et al.
Plos One|January 28, 2014
Increased HEV seroprevalence in patients with autoimmune hepatitisSven Pischke, Anett Gisa, Pothakamuri Venkata Suneetha, et al.
Frontiers in Immunology|February 18, 2025
Identification of novel autoantibodies in Sjögren's diseaseFiona Engelke, Petra Budde, Salvatore De Vita, et al.
Neurological Research and Practice|July 17, 2025
Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritisFranz Felix Konen, Torsten Witte, Diana Ernst, et al.
Rheumatology International|April 15, 2025
Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR databaseLinus Maximilian Risser, Torsten Witte, Matthias Englbrecht, et al.
Autoimmunity Reviews|March 16, 2023
Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disordersFranz Felix Konen, Nora Möhn, Torsten Witte, et al.
Clinical and Experimental Rheumatology|February 6, 2013
The role of the NLRP1 gene in systemic sclerosis: a replication studyMaría Teruel, Carmen P Simeon, Jasper Broen, et al.
Pageof 32

Showing results (211-220 of 317) with videos related to

Sort By:
Pageof 32
Annals of the Rheumatic Diseases|March 11, 2010
Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren's syndromeBeth L Cobb, Yiping Fei, Roland Jonsson, et al.
RMD Open|April 25, 2024
Primary Sjögren's syndrome independently promotes premature subclinical atherosclerosisNadine Zehrfeld, Malin Abelmann, Sabrina Benz, et al.
Joint Bone Spine|April 20, 2023
What is the best referral strategy for axial spondyloarthritis? A prospective multicenter study in patients with suspicious chronic low back painNelly Ziade, Avin Maroof, Bassel Elzorkany, et al.
Neurological Research and Practice|August 23, 2025
Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumabFranz Felix Konen, Gudrun Mechthild Körner, Martin W Hümmert, et al.
Plos One|January 28, 2014
Increased HEV seroprevalence in patients with autoimmune hepatitisSven Pischke, Anett Gisa, Pothakamuri Venkata Suneetha, et al.
Frontiers in Immunology|February 18, 2025
Identification of novel autoantibodies in Sjögren's diseaseFiona Engelke, Petra Budde, Salvatore De Vita, et al.
Neurological Research and Practice|July 17, 2025
Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritisFranz Felix Konen, Torsten Witte, Diana Ernst, et al.
Rheumatology International|April 15, 2025
Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR databaseLinus Maximilian Risser, Torsten Witte, Matthias Englbrecht, et al.
Autoimmunity Reviews|March 16, 2023
Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disordersFranz Felix Konen, Nora Möhn, Torsten Witte, et al.
Clinical and Experimental Rheumatology|February 6, 2013
The role of the NLRP1 gene in systemic sclerosis: a replication studyMaría Teruel, Carmen P Simeon, Jasper Broen, et al.
Pageof 32